Jubilant Life Sciences

07-05-2013 :	JUBILANT FY’13 INCOME FROM OPERATIONS –RS. 5,161 CRORES, UP 21%, EBITDA –RS. 1,055 CRORES, UP 18%, PAT –RS. 153 CRORES, UP FROM RS. 15 CRORES
	The Board of Jubilant Life Sciences Limited, an integrated pharmaceutical and life science company met today to approve financial results for the quarter and year ended March 31, 2013.
09-04-2013 :	JUBILANT LIFE SCIENCES RECEIVES PRESTIGIOUS "NDTV PROFIT BUSINESS LEADERSHIP AWARD 2012 FOR CORPORATE SOCIAL RESPONSIBILITY"
	Jubilant Life Sciences Limited, an integrated Pharmaceuticals and Life Sciences Company announced today that it has received prestigious "NDTV Profit Business Leadership Award 2012" in the category of "Corporate Social Responsibility" at an award ceremony held on April 8, 2013 at New Delhi. On behalf of the Company Mr. Shyam S Bhartia, Chairman & Managing Director, Jubilant Life Sciences Limited received the award from Chief Guest Dr. Montek Singh Ahluwalia, Deputy Chairman, Planning Commission, Government of India.
27-02-2013 :	ANNOUNCEMENT
	Jubilant Life Sciences Limited announced today that one of its manufacturing facility, Jubilant HollisterStier General Partnership (JHS) located at Kirkland, Quebec, Canada has been issued a Warning Letter (WL) by US Food and Drug Administration (FDA) identifying significant violations of current Good Manufacturing Practices (cGMP) Regulations.
29-01-2013 :	JUBILANT Q3 FY'13 INCOME FROM OPERATIONS - RS. 1,306 CRORE, UP 19%YOY EBITDA - RS. 263 CRORE, UP 24%YOY, MARGINS AT 20.2% PAT AT RS 27 CRORE (UP 134%) AFTER EXCEPTIONAL LOSS OF RS 71 CRORE
	The Board of Jubilant Life Sciences Limited, an integrated pharmaceutical and life science industry player met today to approve financial results for the quarter and nine-months ended December 31, 2012.